Persistent vomiting and nausea can lead to dehydration, electrolyte imbalances, and metabolic disturbances that may manifest as dyspnea
[DOI] [PubMed] [Google Scholar] 155.Giustarini D., Dalle-Donne I., Colombo R., Milzani A., Rossi R
Events involving suspected renal, hematologic, neurologic, dermatologic and hepatic effects have also been reported
The mouse research that established its mechanism and preclinical effects used subcutaneous injection at a fixed research dose (20 mg/kg, three times daily) a research-animal protocol, not a human administration guide
Exenatide ER Trade Names: Byetta (daily) Bydureon (weekly - extended release) Generic (Nov 2024) Drug Class: DPP-IV resistant Incretin (GLP-1 like) Mimetic Mechanism of Action: a synthetic analog of glucagon-like-polypeptide 1 (GLP-1) that is resistant to breakdown by DPP-IV
Fact : In July 2023, the European Medicines Agency began reviewing reports of patients causing self-harm or having suicidal ideation after taking weight-loss drugs that contain semaglutide